CHARLOTTETOWN, PE – Today, the Government of Canada and the Government of British Columbia announced a combined $7.2-million investment to create a new biomanufacturing training centre at BCIT, where in partnership… Read More
Intense interest in PharmAla’s best-in-class manufacturing and regulatory excellence continues as PharmAla examines further Australian opportunities VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that,… Read More
Completed NVG-291 dosing of subjects in Phase 1 clinical trial Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury planned to start in Q3 2023 NVG-291 has… Read More
TORONTO, ON — Global investors and strategic pharma licensing teams met with some of Canada’s most promising early-stage health science company leaders and our top research institutions at the OBIO®… Read More
LAVAL, QC — / ACCESSWIRE / — Bausch Health Companies Inc. (NYSE/TSX:BHC) today announced the opening of the 2023 Salix Gastrointestinal Health Scholars Program application period. The program will award 10… Read More
